The emerging field of personalised medicine is offering innovative ways of tackling Europe's health issues. But Europe's healthcare system is not yet fully adapted to take advantage of the possibilities. How can patients get access to the benefits that are on the brink of becoming available through personalised medicine?  This is the theme of the conference organised by European Alliance for Personalised Medicine (EAPM) in Dublin, on 20th and 21st of March 2013. Find out more about the conference here. In the framework of EAPM conference, Breda Flood, EFA President, will speak about U-BIOPRED project at a workshop held by Innovative Medicines Initiative (IMI). Find more information about IMI workshop here.

Dear Visitor,

for regularly updated information on Covid-19 for allergy and respiratory patients, please consult our Covid-19 resource and information hub.
Stay safe!
The EFA Team